Eric J. Ende - Sep 9, 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Todd Branning, as attorney-in-fact for Eric J. Ende
Stock symbol
NBSE
Transactions as of
Sep 9, 2022
Transactions value $
$0
Form type
4
Date filed
9/12/2022, 05:00 PM
Previous filing
Aug 5, 2022
Next filing
Nov 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Stock option (right to buy) Award $0 +37.6K $0.00 37.6K Sep 9, 2022 Common Stock 37.6K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.